Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Glucose and Simvastatin

supplement:

Glucose

Research Papers that Mention the Interaction

Simvastatin compared to placebo significantly reduced plasma total cholesterol (7.9 vs 5.3 mmol·l−1), LDL-cholesterol (7.2 vs …·l−1), triglycerides (2.9 vs 2.1 mmol·l−1), free fatty acids (1106 vs 818 mmol−1) and glucose (7.4 vs …·l−1) levels.
European Journal of Clinical Pharmacology  •  2004  |  View Paper
In subgroup analysis of individual statins, use of atorvastatin, rosuvastatin, pitavastatin and simvastatin had significant association with increase in fasting glucose.
Cardiovascular Diabetology  •  2018  |  View Paper
In the whole population, statin therapy (OR: 4.0, 95% CI 1.1–14.1, p<0.020), and in particular simvastatin and atorvastatin, was associated with increased risk of altered glucose levels or NOD.
Hormones  •  2017  |  View Paper
Superoxide anion production, ER stress, and cell death induced by 27.5 mM dextrose were inhibited by therapeutic concentrations of simvastatin and pravastatin.
American journal of therapeutics  •  2016  |  View Paper
Superoxide anion production induced by 500 mg/dl dextrose was inhibited by therapeutic concentrations of rosuvastatin or simvastatin (10 nmol/l), whereas the increased levels of cellular endothelin 1 mRNA and endothelin 1 in culture media was inhibited by supratherapeutic concentrations of statins (> or =0.1 micromol/l).
Diabetes  •  2006  |  View Paper
Consistent with this idea simvastatin > 0.1 µM reversed activation of VGCCs by glucose but had no significant effect in the sugar's absence.
Toxicological sciences : an official journal of the Society of Toxicology  •  2019  |  View Paper
Simvastatin treatment reduces the levels of glucose , lipid, leptin and neutrophil percentage, and improves airway inflammation and remodeling, which can be as a potential therapeutic target used in the treatment of obese asthma in humans.
Biochemical and biophysical research communications  •  2017  |  View Paper
In OE mice, simvastatin augmented muscular glucose uptake but impaired whole-body insulin sensitivity.
Biomedicines  •  2020  |  View Paper